Literature DB >> 9334901

Electron affinities of p-benzoquinone, p-benzoquinone imine and p-benzoquinone diimine, and spin densities of their p-benzosemiquinones computed by several quantum chemical models.

Y H Mariam1, L Chantranupong.   

Abstract

Restricted and unrestricted (U) Hartree-Fock (HF), second-order Møller-Plesset perturbation (MP2), density functional (DF), hybrid HF/DF and semiempirical (half-electron (HE) method) models have been used to calculate adiabatic electron affinities (EAad values) of p-benzoquinone (I), p-benzoquinone imine (VI) and p-benzoquinone diimine (XI), as well as expectation values (<S2>) and spin density distributions in the radical anions of I, VI and XI. The AM1/AM1-HE and ab initio calculated structures are found to be in accord with each other. The ROHF/6-31G(d) method gave the poorest EAad result. The UHF and UMP2 wave functions were found to be substantially spin contaminated (for the radicals) and the accuracies of the EAad values calculated were also poor. The use of molecular energies obtained after spin annihilation did not lead to significant improvement of the UHF and UMP2 results. In contrast to the ROHF, UHF and UMP2 results, the DF(USVWN, UBVWN, UBLYP) and hybrid HF/DF(UB3LYP) methods, as well as the AM1-HE, gave much better results. The calculated EAad values decreased, as predicted by most of the models, in the order EAad(I) > EAad(VI) > EAad(XI). The differences in the EAs, EAad(I)-EAad(VI) and EAad(I)-EAad(XI), were consistently predicted to be about 8-9 and 17-18 kcal/mol, respectively, by the DF, B3LYP and AM1-HE models. The performance of the PM3 and SAM1 models was not as good as the AM1 model. Of all the methods tested, the B3LYP/6-311G(d,p) model is concluded to give the most accurate quantitative trend (I(42.6) > VI(33.1) > XI(23.7)) in EAad. The predicted trend in EA can satisfactorily be rationalized by the calculated LUMO orbital energies, atomic charges and spin density distributions. Analysis of the spin density data predicts that phenoxyl- and anilino-type radical anions predominate in the p-benzosemiquinones of I and XI, respectively, while both phenoxyl- and anilino-type radicals contribute to the structure of the p-benzosemiquinone of VI, with the anilino-type predominating.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334901     DOI: 10.1023/a:1007903612053

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  6 in total

1.  Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.

Authors:  J W Lown; H H Chen; J A Plambeck; E M Acton
Journal:  Biochem Pharmacol       Date:  1979-09-01       Impact factor: 5.858

2.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

3.  Density-functional exchange-energy approximation with correct asymptotic behavior.

Authors: 
Journal:  Phys Rev A Gen Phys       Date:  1988-09-15

4.  5-Iminodaunomycin. An anthracycline with unique properties.

Authors:  C E Myers; J R Muindi; J Zweier; B K Sinha
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

5.  A computational study on the relative reactivity of reductively activated 1,4-benzoquinone and its isoelectronic analogs.

Authors:  Y H Mariam; A Sawyer
Journal:  J Comput Aided Mol Des       Date:  1996-10       Impact factor: 3.686

6.  Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.

Authors:  K J Davies; J H Doroshow
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

  6 in total
  1 in total

1.  Ultrafast above-threshold dynamics of the radical anion of a prototypical quinone electron-acceptor.

Authors:  Daniel A Horke; Quansong Li; Lluís Blancafort; Jan R R Verlet
Journal:  Nat Chem       Date:  2013-07-07       Impact factor: 24.427

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.